EMA Authorised: Zavicefta (avibactam sodium;ceftazidime pentahydrate) — Pfizer Ireland Pharmaceuticals Unlimited Company

View source ↗

Summary

The EMA authorised Zavicefta (avibactam sodium and ceftazidime pentahydrate) for treatment of pneumonia, soft tissue infections, urinary tract infections, and o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infections
• Pneumonia
• Soft Tissue Infection
• Urinary Tract Infection

Drugs mentioned

• Zavicefta (ceftazidime-avibactam)

Snippet

Status: Authorised. Therapeutic area: Pneumonia, Bacterial;Soft Tissue Infections;Pneumonia;Urinary Tract Infections;Gram-Negative Bacterial Infections. MAH: Pfizer Ireland Pharmaceuticals Unlimited Company. Decision date: 20/05/2025